STAAR Surgical (STAA) – Company Press Releases
-
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
-
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
-
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
-
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
-
STAAR Surgical to Participate in Two Upcoming Investor Conferences
-
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
-
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
-
STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision
-
STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023
-
Lilian Zhou Appointed to STAAR Surgical Board of Directors
-
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)
-
STAAR Surgical Reports Third Quarter 2023 Results
-
STAAR Surgical to Report Third Quarter Results on November 1, 2023
-
STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL)
-
Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL
-
STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023
-
STAAR Surgical to Host “Vision 2026” Investor Day on September 14, 2023
-
Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600
-
STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL
-
STAAR Surgical to Participate in Upcoming Investor Conferences
-
STAAR Surgical Reports Second Quarter 2023 Results
-
STAAR Surgical to Report Second Quarter Results on August 2, 2023
-
EVO ICL Sponsors Jonas Brothers’ The Tour
-
STAAR Surgical Reports First Quarter 2023 Results
-
STAAR Surgical to Report First Quarter Results on May 3, 2023
-
STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
-
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results
-
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023
-
Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses
-
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
-
STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO
-
STAAR Surgical Opens EVO Experience Center in United States
-
STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y
-
STAAR Surgical to Report Third Quarter Results on November 2, 2022
-
Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses
-
STAAR Surgical Patient Awareness Campaign Launched In New York
-
STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems
-
STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y
-
STAAR Surgical to Report Second Quarter Results on August 10, 2022
-
STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)
-
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
-
STAAR Surgical to Report First Quarter Results on May 4, 2022
-
STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.
-
STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses
-
STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results
-
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022
-
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results
-
STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y
-
STAAR Surgical to Report Third Quarter Results on November 3, 2021
-
STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021
Back to STAA Stock Lookup